Genexine제넥신
095700 · KOSDAQ · ₩095700 · 제넥신
₩2,250▼ ₩75 (3.23%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | −24.9% | −8.4% | −42.3% | 34.5% | 71.3% | 86.9% |
| Operating margin | −798.7% | −790.8% | −1,270.0% | −1,046.0% | −211.0% | −42.7% |
| Net margin | −650.0% | −595.0% | −2,172.2% | −1,011.1% | −283.6% | −133.5% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +8.6% | +56.0% | −24.2% | −75.6% | −58.5% | — |
| Operating income growth | −9.7% | +2.9% | +8.0% | −20.8% | −104.9% | — |
| Net income growth | −18.7% | +57.3% | −62.8% | +13.1% | +11.9% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −14.5% | −10.7% | −21.4% | −12.7% | −11.1% | −9.8% |
| Return on assets | −9.2% | −7.6% | −16.8% | −9.7% | −8.7% | −8.0% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 65.8% | 50.5% | 31.9% | 24.2% | 37.4% | 21.7% |
| Net debt to equity | 44.5% | 29.5% | 26.5% | 16.4% | 24.9% | 5.8% |
| Current ratio | 26.8% | 39.2% | 86.9% | 152.8% | 54.4% | 84.9% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Genexine / 제넥신 / 095700 / KRX:095700
Source: KRX statistical information